<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0264980" disease_type="Disease or Syndrome" abbrv="">Purple toes syndrome</z:e> is an extremely uncommon, nonhemorrhagic, cutaneous complication associated with <z:chebi fb="8" ids="10033">warfarin</z:chebi> therapy </plain></SENT>
<SENT sid="1" pm="."><plain>It is characterized by the sudden appearance of bilateral, painful, purple lesions on the toes and sides of the feet that blanch with pressure </plain></SENT>
<SENT sid="2" pm="."><plain>The syndrome usually develops 3-8 weeks after the start of <z:chebi fb="8" ids="10033">warfarin</z:chebi> therapy </plain></SENT>
<SENT sid="3" pm="."><plain>A 47-year-old man with a history of <z:e sem="disease" ids="C0264980" disease_type="Disease or Syndrome" abbrv="">purple toes syndrome</z:e> that resolved after discontinuing <z:chebi fb="8" ids="10033">warfarin</z:chebi>--prescribed for a <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> (DVT) in his right lower leg--experienced an <z:hpo ids='HP_0011009'>acute</z:hpo>, proximal DVT in his other leg </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="8" ids="10033">Warfarin</z:chebi> again was prescribed; 1 week later, <z:e sem="disease" ids="C0264980" disease_type="Disease or Syndrome" abbrv="">purple toes syndrome</z:e> developed in that extremity </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="8" ids="10033">Warfarin</z:chebi> therapy again was discontinued, and intravenous unfractionated <z:chebi fb="5" ids="28304">heparin</z:chebi> was started; the patient's clinical picture indicated a possible <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo>, and laboratory analysis suggested <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The patient's toe pain resolved, but the purple discoloration persisted </plain></SENT>
<SENT sid="7" pm="."><plain>Follow-up laboratory analysis confirmed <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, and <z:chebi fb="8" ids="10033">warfarin</z:chebi> was restarted with close monitoring </plain></SENT>
<SENT sid="8" pm="."><plain>No further complications occurred with long-term therapy </plain></SENT>
<SENT sid="9" pm="."><plain>Although a rare complication of therapy, clinicians should monitor for the development of <z:e sem="disease" ids="C0264980" disease_type="Disease or Syndrome" abbrv="">purple toes syndrome</z:e> in patients taking <z:chebi fb="8" ids="10033">warfarin</z:chebi> </plain></SENT>
</text></document>